H1B Salary Data

Home › Employers › The Mary Lanning Memorial Hospital Association

The Mary Lanning Memorial Hospital Association: H-1B salaries and sponsorship

The Mary Lanning Memorial Hospital Association filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $73,944.

Applications (LCAs)3
Certified3
Employer addressHastings, NE
H-1B dependent employerNo
Median offered salary$73,944
Middle half of salaries$72,103–$361,972
10th–90th percentile$70,998–$534,789

Does The Mary Lanning Memorial Hospital Association sponsor H-1B visas?

The Mary Lanning Memorial Hospital Association filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jul 16, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Medical Laboratory Scientist2$72,103
Medical Oncologist1$650,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20253$73,944

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Medical Laboratory Scientist$73,944
Level II
Hastings, NEJul 16, 2025Nov 15, 2025Certified
Medical Laboratory Scientist$70,262
Level II
Hastings, NEJul 16, 2025Nov 15, 2025Certified
Medical Oncologist$650,000Hastings, NEFeb 7, 2024Jul 1, 2024Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).